Human papillomavirus (HPV): making the case for 'Immunisation for All'

Area of Science:

• Oncology
• Infectious Diseases
• Public Health

Background:

• Human papillomavirus (HPV) is a common sexually transmitted infection linked to various diseases, including genital warts, benign oral lesions, and HPV-related malignancies.
• High-risk HPV types are increasingly associated with rising rates of head and neck cancers, particularly oropharyngeal cancer.
• Current HPV vaccination strategies vary, with some countries implementing female-only programs relying on herd immunity or targeted vaccination for men who have sex with men.

Purpose of the Study:

• To evaluate the effectiveness of different HPV vaccination strategies.
• To propose universal HPV vaccination as the optimal approach for disease control.
• To address the limitations of current vaccination programs in protecting both males and females.

Main Methods:

• Review of existing literature on HPV infection, HPV-related diseases, and vaccination effectiveness.
• Analysis of the potential impact of universal versus selective HPV vaccination programs.
• Argumentation for the ethical, practical, and cost-effectiveness of universal vaccination.

Main Results:

• HPV infection causes significant health issues, including cancers, with a notable rise in HPV-linked head and neck cancers.
• HPV vaccination is effective against cervical and anogenital cancers and shows potential for preventing oropharyngeal cancers.
• Existing vaccination programs relying on herd immunity or targeted approaches may have limited effectiveness.

Conclusions:

• Universal HPV vaccination for both males and females is proposed as the most effective, practical, ethical, and potentially cost-effective solution.
• This strategy could lead to better control of HPV-related diseases in the general population.
• Universal vaccination ensures comprehensive protection against HPV, irrespective of gender or sexual orientation.